Inventages Venture Capital Investment is the venture investment arm of Nestlé, focused on growth and early-stage opportunities across health care, life sciences, cosmeceuticals, pharmaceuticals, enabling technologies and services, diagnostics, and medical devices. It pursues seed through late-stage investments, including mezzanine and bridge financing, and targets middle-market and mature companies. Its portfolio interests span small molecules, proteins, antibodies, vaccines, phytopharmaceuticals, natural compounds, botanicals, antibiotics, and therapeutics; diagnostic areas such as genetic materials, biomarkers, pharmacogenomics, and analytical tools; enabling technologies including packaging, production technologies, supply chain management, and novel materials, as well as innovative preventive and therapeutic concepts. It also backs companies in nutraceuticals, functional foods, dietary supplements, oral and skin care, immune modulation, and health management. The firm seeks to create value through financial and strategic support across stages while leveraging Nestlé’s global resources.